In patients with type 2 diabetes mellitus, prolonged QT dispersion or Tpeak-Tend interval have been reported by the authors and other groups to be improved by SGLT2 inhibitors (58–60). The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.